Dr. Bijan Almassian is a co-founder, President and CEO of CaroGen Corporation. Prior to CaroGen, Dr. Almassian served as President and CEO of ExSAR Corp, COO of Panacea Pharmaceuticals, and Vice President of Drug Development at Vion Pharmaceuticals. Dr. Almassian holds a MS and PhD from...
Bijan Almassian, President and Chief Executive Officer, CaroGen Corporation
Javad Aman has been the President and Chief Scientific Officer (CSO) of Integrated BioTherapeutics, Inc. (IBT), a US biotechnology company focused on the discovery of vaccines and immunotherapeutics for emerging infectious diseases. Since 2007, he has led a group of 40 people working on several...
M Javad Aman, President and Chief Scientific Officer, Integrated BioTherapeutics
A dynamic and well-published immunologist with broad expertise in the areas of vaccine development, autoimmunity and tumor immunology, Dr. Anderson joined VBI full time in 2009 from Harvard Medical School, where he held a position as Assistant Professor. Dr. Anderson is an inventor of much of the...
David Anderson, Chief Scientific Officer, VBI Vaccines
Raiees Andrabi is an Institute Investigator in the Department of Immunology and Microbiology at The Scripps Research Institute. Raiees Andrabi earned his PhD degree from the All India Institute of Medical Sciences in Biochemistry and performed his postdoctoral work in Dennis Burton’s laboratory at...
Raiees Andrabi, Institute Investigator, Scripps Reseach, La Jolla, CA
Pervin Anklesaria leads the HIV vaccines and biologics prevention efforts for the foundation’s HIV team. She joined the foundation in 2011 as a consultant and in 2012 became a senior program officer working on the foundation’s HIV vaccine and biologics initiatives.
Pervin has held leadership roles ...
Pervin Anklesaria, Deputy Director, The Bill & Melinda Gates Foundation
Khursheed Anwer, PhD, MBA, assumed the title of Executive Vice President and Chief Science Officer, upon Celsion’s June 2014 acquisition of EGEN, Inc., where he was President and Chief Science Officer, a position he held since 2009. He joined EGEN, Inc. in July, 2002, as Vice President of Research...
Khursheed Anwer, Executive Vice President & Chief Scientific Officer, Imunon, Inc.
After obtaining a PhD in Microbiology at the University of Aix-Marseille and an EMBA in Healthcare Management at the University of Lausanne, Joshua Armitano joined ExcellGene in 2020 to manage several cell line development program including a Covid antigen development project supported by CEPI.
Joshua Armitano, Program Officer, ExcellGene SA
Kimberly Armstrong, Ph.D., MT (ASCP) is the Chief of the Therapeutics Branch in the Influenza and Emerging Infectious Diseases Division at the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the...
Dr Kimberly Armstrong, Chief of the Therapeutics Branch in the Influenza and Emerging Infectious Diseases Division, BARDA
Jared Baeten, MD, PhD is Vice President of Clinical Development at Gilead Sciences, leading the company's strategy for HIV Treatment, Prevention, and Cure.Jared has conducted extensive research over the past two decades focusing on the prevention of HIV globally, including clinical...
Jared Baeten, Vice President, HIV Clinical Development, Gilead Sciences
Dr. John Baldoni has developed an expansive portfolio over 40+ years in the pharmaceutical industry. His previous positions include Senior Vice President of Drug Discovery, and Senior Vice President of Platform Technology and Science (PTS) at GSK Pharma R&D. His experience spans chemical entity ...
John Baldoni, Head of Science, SaponiQx
Ashley Birkett is the Global Head of Malaria within PATH’s Center for Vaccine Innovation and Access (CVIA) and serves on the CVIA Leadership Team. CVIA brings together expertise across every stage of vaccine research, development, and introduction to make vaccines globally available to...
Ashley Birkett, Global Head, Malaria Vaccines and Biologics, PATH
After obtaining his Masters degree in Pharmaceutical Sciences, Philip pursued his research interest as a graduate student at the Amsterdam University Medical Center. Under the mentorship of Prof. Rogier Sanders, as well as Dr. Neil King at the University of Washington, he worked on the development...
Philip Brouwer, Postdoctoral fellow, Scripps Research
Dr. Caldwell is the Associate Vice President, Vaccine Research & Education at Meharry Medical College in Nashville TN. He leads the emerging partnership between Meharry and Clinical Research Associates of Nashville and is a devoted clinician and teacher. Dr. Caldwell serves as an investigator...
Michael Caldwell, Assoc VP Vaccine Research & Education, Meharry Medical College
Dr. Cicic is Senior Vice President of Clinical Development. Dr. Cicic has 20 years of experience in the biopharmaceutical industry. Before joining SELLAS, he was a Senior Vice President, Clinical Lead, at Klus Pharma, a wholly owned U.S. subsidiary of Kelun, a major China-based multinational...
Dragan Cicic, SVP of Clinical Development, SELLAS Life Sciences Group AG
Colonel Matthew G. Clark is the Joint Project Manager for Chemical, Biological,Radiological, and Nuclear Medical (JPM CBRN Medical). He is responsible for leading themedical portfolio for the Joint Program Executive Office for Chemical, Biological,Radiological and Nuclear Defense (JPEO-CBRND).COL...
Matthew G. Clark, Joint Project Manager, CBRN Medical, JPEO-CBRND
Dr. Alexander Cohen is a postdoctoral scholar in the Bjorkman lab at Caltech which is also where he received his PhD in Biochemistry and Molecular Biophysics (2021). His graduate and postdoctoral work have focused mainly on the development of a mosaic nanoparticle vaccination strategy for SARS-like ...
Alexander Cohen, Post-Doctoral Scholar, Division of Biology and Biological Engineering,, California Institute of Technology
Ezra Cohen, MD, is Chief of the Division of Hematology-Oncology, and Co-Director of the San Diego Center for Precision Immunotherapy. A physicianscientist, Dr. Cohen led an independently funded laboratory interested in mechanisms of action of novel therapeutics. He has made major contributions to...
Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center
Mr. Gerald Commissiong, Chief Executive Officer, Todos Medical Ltd.
Dr Peter Daszak, President, Ecohealth Alliance Inc.
Mr. Datlof is the Chief, Business Development and Commercialization in the Office of Medical Technology Transfer at the U.S. Army Medical Research and Materiel Command. He has commercialized biomedical and IT technologies in the university, nonprofit, for-profit, and government sectors. He owns...
Barry Datlof, Chief, Business Development and Commercialization, U.S. Army Medical Research and Development Command
Dr. DeBord is the Acting Deputy Assistant Secretary for the Office of Strategy, Policy, Planning, and Requirements (SPPR) within the Administration for Strategic Preparedness and Response (ASPR). She provides leadership and oversight to the office, ensuring ASPR’s operational preparedness and...
Kristin DeBord, Acting Deputy Director, Office of Strategy, Policy, Planning & Requirements, Department of Health and Human Services
Jennifer DeMarco obtained her Master’s of Science at the University of Virginia, with an emphasis in immunology and infectious disease and a specialty in vaccine and therapeutic development. During the SARS-CoV-2 pandemic, her work was at the front of the field with assay and model development for ...
Jennifer DeMarco, Project Leader, Custom Assay Design and Development, Microbiologics
Dr. Dervan has more than 20 years of biopharmaceutical drug-development expertise, from bench to commercialization, including development of a broad range of immuno-oncology therapeutics. He is a graduate of Sheffield University Medical School, UK, where he obtained his Ph.D., in Molecular...
Joe Dervan, Vice President of Research and Development, P.D.S. Biotechnology Corp
Dr. Diaz is the Associate Director, Research and Development, Eurofins Viracor BioPharma. She has over 6 years of experience in the pharmaceutical CRO industry. Her wide range of experience includes developing Immunoassays and viral diagnostic assays to support clinical trials. She has interest and ...
Dr Manisha Diaz, Associate Director, Research and Development, Eurofins Viracor BioPharma
Dr. Carl W. Dieffenbach is the Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Under his leadership, the Division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related...
Carl Dieffenbach, Director, Division of AIDS, NIAID/NIH
Dr. Robert O. Dillman, M.D., is Chief Medical Officer of AIVITA Biomedical. Previously, Dr. Dillman served as Vice President of Oncology at Caladrius Biosciences, Inc. (formerly Neostem, Inc.), a leading development and manufacturing partner to the cell therapy industry. From May 2014 to January...
Robert Dillman, Chief Medical Officer, AIVITA Biomedical, Inc.
Current work involves training (both for internal staff and for external medical professionals) and speaking to external audiences on vaccine development and immunology. Also involved in drafting policy documents in the area of vaccine development, public health and immunodiagnosis.
Mark Doherty, Senior Manager, Global Medical Affairs, GSK
Paul L. Domanico joined CHAI in 2012 as the Senior Director of Global Health Sciences at CHAI. His department partners with industry, academia, and other global health organizations to advance adult and pediatric care, and support CHAI's mission to transform global health. Paul founded...
Paul Domanico, Senior Director of Global Health Sciences,, Clinton Health Access Initiative (CHAI)
Helen Dooley obtained her PhD at the University of Aberdeen, UK. After a post-doc at the University of Maryland, Baltimore, USA, she spent a few years working in the Global Biotherapeutics division of Wyeth, retaining this role with Pfizer post-takeover. She is now Assistant Professor at University ...
Helen Dooley, Assistant Professor, University of Maryland School of Medicine
R. Paul Duffin is a Senior Manager of Drug Product Development at Emergent BioSolutions, and has worked extensively on the development and clinical preparation of the CVD 103-HgR Cholera vaccine.
Paul Duffin, Sr. Manager, Product Development, Emergent Biosolutions
Cynthia “Cindy” Dukes, PA, MT, is Chief Business Officer to Benchmark Research, a 9 site multitherapeutic clinical research network that was founded 25 years ago with a core focus on vaccine studies. Cindy is a world-recognized professional in the vaccine industry. She has over 40 years of...
Cynthia Dukes, CBO, Benchmark Research
Dr. Dutta is a Professor and Researcher with sustained international recognition who has risen to the top of his field of endeavor, that being in cybernetics and systems medicine. Dr. Dutta joined the University of Connecticut as an Assistant Professor, a tenure-track position, in August 2016 and...
Dr Abhishek Dutta, Assistant Professor, University of Connecticut
Dr. Scot Ebbinghaus joined Merck Research Labs Late Stage Oncology Development in 2007. He is currently Vice President and Therapeutic Area Head for Late Stage Oncology Development with responsibilities for overseeing the Keytruda (pembrolizumab) development program and other late stage assets in...
Scot Ebbinghaus, Vice President and Therapeutic Area Head for Late-Stage Oncology Clinical Development, Merck
Dr. Eichberg is Director of Strategic Alliances at Merck Research Laboratories, where he oversees collaborations in multiple therapeutic areas and with a variety of partners, including biopharmaceuticals, academic researchers, NGOs, and government agencies. In this role, Dr. Eichberg is involved...
Dr Michael Eichberg, Strategic Alliances Director, Merck
Dr Shirit Einav received an M.D. from Tel-Aviv University, Israel. She completed her residency in Internal Medicine at the Beth Israel Deaconess Medical Center (Harvard Medical School) followed by fellowship in Infectious Diseases at Stanford, then pursued a research postdoctoral fellowship at...
Shirit Einav, Associate Professor of Medicine, Stanford University
Eric Elander, Account Manager, Clinical Research IO (CRIO)
Dr. Annie Elong Ngono is Research Instructor in the Center for Infectious Disease and Vaccine Research at the La Jolla Institute for Immunology (LJI). She received her Ph.D. in Immunology working on the role of autoreactive T and B cells in periphery using blood samples from patients with multiple...
Annie Elong Ngono, Instructor, Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology
Dr Flaherty received his Doctor of Pharmacy degree from the University of Southern California, School of Pharmacy, after which he completed a clinical residency and Infectious Diseases fellowship at the University of California at San Francisco (UCSF). After serving as a clinical faculty member at...
John Flaherty, Executive Director, Virology Clinical Development, Gilead Science
Dr. David Foster brings more than 20 years of experience working with early stage pharmaceutical and biotechnology companies developing a variety of therapeutics from biologics to small molecules. He has represented pharmaceutical, biotherapeutic and diagnostic companies, while in private legal...
David Foster, Chief Executive Officer, Island Pharmaceuticals
Chardae Foster is a medical student at Meharry Medical College in Nashville, TN. She earned her BS at the University of Tennessee, Knoxville where she majored in Neuroscience in pursuit of a medical career in Neurology. Her passion to become a Neurologist was sparked by her brother who has Epilepsy ...
Chardae Foster, Medical Student; Lead, Physician Education & Training Program, Meharry Medical College
Barbara A.K. Franklin, PhD is Owner/Director of All One Communication. As a specialist in communication for health and development, she has worked worldwide for 30 years supporting United Nations agencies, multilateral, bilateral, NGO and national teams in communication for change. She often works ...
Barbara Franklin, Director, All One Communication
Dr. Frueh was previously CSO at Human Longevity, Inc. He was the President of the Medco Research Institute and the first Associate Director for Genomics at FDA. In addition, he held executive positions in multiple biotechnology companies and serves on the Boards of several biotechnology...
Dr Felix Frueh, CSO and Co-Founder, Selva Therapeutics, Inc.
Siva Gandhapudi, Director, Immunology Operations, P.D.S. Biotechnology Corp
Dr Howard Gendelman, Co-founder, Exavir Therapeutics
Bethany (Biron) Girard is the Associate Director – Clinical Biomarkers, Infectious Disease at Moderna Inc. and has been with the company since Oct 2020. In this role she serves as a scientific leader and point of contact for clinical teams in the Infectious Disease (ID) space, driving pivotal...
Bethany Girard, Associate Director, Clinical Biomarkers, Moderna
Jacob Glanville is an serial entrepreneur, and computational immuno-engineer. He built and sold his first company Distributed Bio from founding in March of 2012 to a 104M dollar sale to Charles River Laboratories in December of 2020. During that period, he developed the core business model, the...
Jacob Glanville, Chief Executive Officer, Centivax
Jeffrey Glenn, M.D., Ph.D. is a Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology at Stanford University School of Medicine, and the Director of the Center for Hepatitis and Liver Tissue Engineering. He also heads a research laboratory focused...
Jeffrey Glenn, Professor of Medicine and of Microbiology & Immunology, Stanford University
Dr. Ilya Goldberg has spent the majority of his career at the intersection of biology and imaging, and played a leading role in the development of image informatics and machine learning for bio-medical imaging since the emergence of these fields in the late '90s. At ViQi, Ilya leads development ...
Dr Ilya Goldberg, CSO, ViQi, Inc
Ananda Goldrath is a Tata Chancellor’s Professor in the Division of Biological Sciences and former chair of the Molecular Biology Section at the University of California, San Diego, where she started her lab in 2004.
Ananda Goldrath, Tata Chancellor's Endowed Professor in Molecular Biology, UCSD
Peter Goldstein, Executive Director of Vaccine Platform Development. Peter has 18 years of experience managing multidisciplinary scientific and technical programs. He plays a central role in management of ILiAD’s assay development, clinical serology, and Quality Management System, and is...
Peter Goldstein, Executive Director, Vaccine Platform Development, Iliad Biotechnologies
Dr Phil Gomez, Chief Executive Officer, SIGA Technologies, Inc.
Dr Jay Grobler, Associate Vice President Infectious Disease and Vaccines, Merck And Company
Sha Ha is the Vice President of CMC at IGM Biosciences. She oversees drug substance and drug product development as well as analytical development in the Doylestown PA site. Before joining IGM, Sha was the director of Vaccine Process Development and Commercialization at Merck. She managed Phase 3...
Sha Ha, VP, CMC, IGM Infectious Diseases, Inc.
Academy Award nominee Scott Hamilton Kennedy is a writer, director, producer, cameraman, and editor and has worked on everything from music videos and commercials to motion capture animation, scripted and reality television, and fiction and non-fiction film.
Scott Hamilton Kennedy, Director, Black Valley Films
Colin Havenar-Daughton is a Director of Immunology at Vir Biotechnology. He earned his PhD degree in Immunology from the University of Washington. Colin conducted postdoctoral studies in Shane Crotty’s laboratory at the La Jolla Institute, where he focused on the immunological underpinnings of...
Colin Havenar-Daughton, Director of Immunology, Vir Biotechnology
Erik Heegaard is a medical specialist, PhD, DMSc, and works as Chief Medical Officer at Evaxion. He is responsible for strategic development and tactical implementation of the clinical studies for Evaxion’s research programs. This includes providing direct medical/physician oversight for phase I/II ...
Erik Heegaard, CMO, Evaxion Biotech A/S
Danielle Horneman, PhD., works as a technical lead at Batavia Biosciences, where she provides scientific input and writes proposals for viral vector and viral vaccine process development and manufacturing projects.Danielle has a profound background in process development and production of...
Danielle Horneman, Project Manager, Bioprocess Scientist, Batavia Biosciences
Nigel Horscroft D.Phil. is Chief Scientific Officer and Executive Vice President for Preclinical Research at Atriva Therapeutics, a German biopharmaceutical company developing antiviral therapies. Dr. Horscroft holds a D.Phil. in Biochemistry from Oxford University where he studied Bluetongue Virus ...
Nigel Horscroft, Chief Scientific Officer, Atriva Therapeutics
Richard Hughes IV, J.D., M.P.H. is a Partner at the Washington, D.C. health care law firm, Epstein, Becker & Green and a Professorial Lecturer in Law at the The George Washington University Law School. His practice, teaching and thought leadership focus on access to preventive health...
Richard Hughes, Partner, Epstein, Becker & Green, Professorial Lecturer in Law,, The George Washington University Law School
Dr. Aeron Hurt is the Principal Global Medical Director, for both COVID-19 and Influenza at Roche, Basel, Switzerland. Aeron was previously Head of the Antiviral Susceptibility Analysis Surveillance Unit and Research group at the WHO Collaborating Centre for Reference and Research on...
Dr Aeron Hurt, Principal Global Medical Science Director, Influenza and COVID-19, Roche
Dr. Peter Jahnmatz is an Immunologist with a PhD in immunology and infectious diseases from the Karolinska Institute in Sweden. He has worked extensively with cell-based immunoassay optimization and antibody development.
Peter Jahnmatz, Research And Development, Mabtech
Stephen Albert Johnston is the inventor of Calviri’s central technologies. In addition to Calviri, he has been a founder of Eliance, Inc. (Macrogenics), Synbody Biotechnology and HealthTell (iCx), Inc. He is Director of the Arizona State University Biodesign Institute’s Center for Innovations in...
Stephen Albert Johnston, Co-Founder, CALVIRI
Robert Jordan is a Senior Program Officer at the Bill and Melinda Gates Foundation. Prior to joining the BMGF, Robert was Vice President of Research and Development at Meissa Vaccines developing live attenuated virus vaccines for RSV and SARS-CoV-2 as well as other respiratory virus...
Dr Robert Jordan, Senior Program Officer, Bill & Melinda Gates Foundation
Neeraj Kapoor, Director, Scientific Leader, Group A Strep and Periodontitis Vaccine Programs, Vaxcyte
Nektaria Karavas, Business Development Director, Aptar Pharma
Kaumaya is Professor of Medicine in Department of Ob/Gyn at the OSU Wexner Medical Center and the James Comprehensive Cancer Center. Dr Kaumaya is internationally recognized as an expert in the fields of vaccine research with emphasis on peptide vaccines for cancer, viral diseases as well as...
Pravin Kaumaya, Professor and Director Vaccine Research, The Ohio State University Werner Medical Center
Sanjay Khare, EVP, Head of Immuno-Oncology Research, Coherus BioSciences
Dr. Killeen joined Matrivax as Chief Scientific Officer in 2009. He has extensive training in the fields of vaccinology, molecular biology, microbiology, protein chemistry, and immunology. Dr Killeen’s experience includes identifying and leading the in-licensing effort of the rotavirus vaccine...
Kevin Killeen, CSO, Matrivax
Dr. Jocelyn Kim is currently an Assistant Professor at UCLA. She received her undergraduate and medical degrees from the University of Michigan, Ann Arbor. She completed her internal medicine residency at Johns Hopkins Hospital in Baltimore, Maryland. Her clinical infectious disease fellowship was...
Dr Jocelyn Kim, Assistant Professor, University of California, Los Angeles
Dr. Richard Kornbluth is an immunologist, physician, and serial entrepreneur. Richard trained at Harvard (A.B.), New York Medical College (M.D.), Columbia University (Ph.D.), and the Scripps Research Institute (postdoc). He was a faculty member at Univ. Calif. San Diego where he worked on HIV...
Richard Kornbluth, President & Chief Scientific Officer, Multimeric Biotherapeutics, Inc.
Dr. Andrey Kovalevsky is a structural biologist, biochemist and a Senior R&D Scientist at the Oak Ridge National Laboratory. Dr. Kovalevsky studied organic chemistry and chemical crystallography at Kharkiv State University, Kharkiv, Ukraine, receiving M.Sc. degree with Honors. He received his...
Dr Andrey Kovalevsky, Senior R&D Scientist, Oak Ridge National Laboratory (ORNL)
Alison Kraigsley is the TB Vaccines Program Officer at the Bill and Melinda Gates Foundation and is responsible for developing and managing a portfolio of research investments to address scientific gaps and support the development of a robust TB vaccine pipeline. Alison has a broad background in...
Alison Kraigsley, Program Officer, TB Vaccines, The Bill & Melinda Gates Foundation
Mara Kreishman-Deitrick, Deputy Commander, United States Army Medical Material Development Activity
Executive with the ability to provide strategic leadership across all phases of drug development based upon 20 years’ experience managing large, technically complex, programs and product portfolios, with increasing influence from academia through private industry, in pursuit of Food and Drug...
Rebecca Kurnat M.S., Head of Product, SaponiQx
Max Lataillade VP Head of global Research Strategy, is responsible for global research and development strategy for the HIV pipeline at ViiV Healthcare, the only company 100% dedicated to HIV. He oversees end-to-end R&D activities for all novel HIV pipeline programs designed to address key...
Max Lataillade, Vice President, Head of Global Research Strategy, ViiV Healthcare
Brett Leav, MD is Head of Clinical Development for Public Health Vaccines at Moderna. He was responsible for overseeing the Moderna COVID-19 vaccine clinical program in adults and children and now leads development of other vaccines to prevent intractable public health challenges, including...
Brett Leav, Head, Clinical Development, Public Health Vaccines, Moderna
Seth Lederman is CEO of Tonix Pharmaceuticals. Prior to Tonix, and his career in Biotech, Dr. Lederman served as tenured Associate Professor at Columbia University and directed basic science research in molecular immunology, infectious diseases and the development of therapeutics for autoimmune...
Dr Seth Lederman, Co-Founder, Chief Executive Officer & Chairman, Tonix Pharmaceuticals
Sam Lee, Ph.D., is President, Interim Co-CEO and co-founder of Cocrystal Pharma Inc., Bothell, Washington, founded in 2007. Cocrystal Pharma Inc. (NASDAQ: COCP) is developing novel small molecule antivirals for the treatment of COVID-19, Influenza, Norovirus, and Hepatitis C. He served on the...
Sam Lee, President, Cocrystal Pharma, Inc.
Haoyang recieved his PhD in Pathogenic Organisms from Fudan University and works at La Jolla Institute.
Haoyang Li, Instructor, Center for Infectious Disease and Vaccine Research, La Jolla Institute
Dr. Hongmin Li is a Professor in the Department of Pharmacology and Toxicology and R. Ken and Donna Coit Endowed Chair in Drug Discovery at College of Pharmacy, the University of Arizona, Tucson AZ, USA. He received bachelor’s degree from Beijing University in 1990. Dr. Li graduated with PhD degree ...
Hongmin Li, Professor, The University of Arizona
Liqin Liu currently is a Sr Director, head of T-cell engager programs at IGM Biosciences. In this role she oversees all T-cell engager research projects and serves as a scientific leader and expertise for T-cell engager portfolio/strategy development. Before joining IGM Biosciences, Liqin worked...
Liqin Liu, Head T-Cell Engager Projects, Immuno-Oncology Research Group, IgM. Biosciences Inc
Bruce Lyday has been a researcher in the fields of virology, immunology, and oncology for over 30 years. He developed a cancer immunotherapy that combines an oncolytic, immune stimulating virus, Dengue-1 #4AZ5, developed by the US Army as a vaccine, in combination with tumor peptide-pulsed...
Bruce Lyday, CEO, Coronavax LLC
Dr. Jaione Maiz is a Principal at Anzu Partners with a focus on investing at the intersections of life science and innovative technology. She also supports portfolio companies in business development, strategy, and product development. Prior to Anzu, Jaione was a Director of Business Development at ...
Jaione Maiz, Principal, Anzu Partners
Alex Mann has a specific interest in the use of human challenge models to answer key questions around host responses to infection as well as efficacy of treatments and vaccines. Over the last 23 years at hVIVO (formally Retroscreen Virology Ltd.) he has led, managed, designed, and analysed an array ...
Alexander Mann, Senior Director, Clinical Sciences, hVIVO
Upendra Marathi, PhD, MBA is the CEO and a co-founder of 7 Hills Pharma. He is an inventor of their first-in-concept technology and a significant investor in the company. He has led the development of three novel pain and cardiovascular drugs, including one recently approved by the FDA. He...
Upendra Marathi, Chief Executive Officer, 7 Hills Pharma LLC
Joshua is an engineer with over 20 years of experience as a CEO. He is a multi-patent inventor, including anti-viral applications of Maxwell's platform technology. His background includes leading engineering teams, as well as military and commercial intelligence. He is a pioneer in the field of ...
Joshua McClure, Chief Executive Officer & Chairman, Maxwell Biosciences
Andrew T. Miller, Ph.D. is the Vice President of Immunology and Operations, and co-founder of Apros Therapeutics, a clinical stage biotech focused on tissue-targeted TLR7 agonists for cancer immunotherapy, infectious disease, and vaccine adjuvants. Andrew has a strong track record of leading small...
Andrew Miller, VP Immunology & Operations, Apros Therapeutics
Dr. Minev is a highly accomplished physician-scientist with extensive industrial and academic experience in Immuno-Oncology, oncolytic viruses and stem cell biology and applications. He has a significant track record in tumor immunology and cancer vaccine development, having worked closely on the...
Boris Minev, President, Medical & Scientific Affairs, Calidi Biotherapeutics
Phillip Monk, CSO, Synairgen Research Ltd
Since 2001 Dr. Mowatt has directed the technology transfer program at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). His team of fifty talented professionals includes scientists, attorneys, and former business persons who facilitate...
Michael Mowatt, Director, Technology Transfer And Intellectual Property Office, National Institute of Health - NIAID
Dr. Newman has more than 30 years’ experience in the biotechnology sector serving in senior management roles at GeoVax (Atlanta, GA), PaxVax (San Diego, CA), Pharmexa (Horsholm, Denmark), Epimmune (San Diego, CA), Vaxcel (Atlanta, GA), Apollon (Philadelphia, PA) and Cambridge Biotech (Boston, MA)...
Mark Newman, CSO, GeoVax, Inc.
Dr. Gabriel Ozorowski has over 16 years of experience in protein structural biology, with a background in applying x-ray crystallography and cryo-electron microscopy (cryoEM) techniques to biomedical studies. He focuses on conformational states of HIV-1 Env and how they are affected by ligands...
Gabriel Ozorowski, Sr. Laboratory Director, The Scripps Research Institute
Dr. Palmer received her undergraduate degree in Biological Sciences from the University of Oxford, and her PhD in Immunology from Imperial College London. Following two postdoctoral fellowships at University College London and Harvard Medical School, Dr. Palmer joined the Ragon Institute of...
Christine Palmer, Senior Director, Immunology,, Gritstone bio
Dr. Pantophlet completed his PhD at the University of Leiden, subsequent postdoctoral training at the Scripps Research Institute, and a one-year fellowship at Research Center Borstel. He began as a tenure track Assistant Professor in the Faculty of Health Sciences (FHS) at Simon Fraser University...
Dr Ralph Pantophlet, Professor, Simon Fraser University
Aleksandra Pastrak M.D Ph.D, Chief Medical Officer, is a medical professional with 23 years of experience in the life sciences industry, developing small molecules and biologic therapeutics for a diverse array of indications. Prior to joining Providence Therapeutics, Dr. Pastrak served as Medical...
Aleksandra Pastrak, CMO, Providence Therapeutics Holdings, Inc.
Dr Meghan Pennini, Chief Therapeutics Officer, HCORE, HHS
Dr. Edward Pham is an instructor in medicine (Division of Gastroenterology and Hepatology) at Stanford University School of Medicine. He is also the deputy director for translational research of ViRx@Stanford, the Stanford Biosecurity and Pandemic Preparedness Initiative, which focuses on...
Edward Pham, Deputy Director Translational Research, ViRx@Stanford, Instructor in Medicine, Stanford University
I am Senior Scientist at Collaborations Pharmaceuticals. I joined the company in 2018 and I am involved in drug discovery projects for rare genetic diseases, neglected diseases and antiviral research. At Collaborations, I am responsible for leading, managing and executing R&D projects in...
Ana Puhl, Associate Director, Collaborations Pharmaceuticals
Professor Bali Pulendran is the Violetta L. Horton Professor at the Stanford University School of Medicine, and a member of the Institute for Immunology, Transplantation and Infection, and the Departments of Pathology and Microbiology & Immunology at Stanford University. He is also an adjunct...
Bali Pulendran, Professor, Department Of Pathology, Microbiology And Immunology, Stanford University School of Medicine (USA)
Kamal Puri is the Chief Scientific Officer at OncoResponse Inc. He has over 25 years of R&D experience in immunology, oncology, and neurobiology. Kamal joined OncoResponse from Celgene, where he led efforts for immunology discovery. Prior to Celgene, he was at Gilead and contributed to the...
Kamal Puri, CSO, OncoResponse
Barbara A. Rath, MD PhD is a board-certified pediatric consultant and infectious disease specialist with 20 years experience in clinical trials, public health and virology in the US, Latin America and Europe. Dr. Rath is honorary professor at the University of Nottingham School of...
Dr Barbara Rath, Co-founder & Chair, Vaccine Safety Initiative; Chair, ISIRV Epi Group, Board Member, ISIRV & ESCMID/ESGREV, Vaccine Safety Initiative
Obtaining her PhD in Biotechnology from the University of Pune, Pratima Rawat is a research scientist with over 12 years of multidisciplinary experience in preclinical and clinical research. She has experience in a variety of fields such as infectious disease biology, virology, HIV biology, and...
Dr Pratima Rawat, Virology Scientist, Microbiologics
Dr. John Redd is an internist and medical epidemiologist whoserved as the Chief Medical Officer (CMO) of the Office of theAssistant Secretary for Preparedness and Response (ASPR) atHealth and Human Services Headquarters in Washington, DCuntil he left government service in January 2022.Dr. Redd...
John Redd, CMO, The Medical Countermeasures Coalition
Steve Reed is the co-founder, President, and CEO of HDT Bio, based in Seattle, USA. His academic appointments include Adjunct Professor of Medicine at Cornell University Medical College Research Professor of Pathobiology at the University of Washington. Dr. Reed received a PhD in Microbiology and...
Steven Reed, Chief Executive Officer, HDT Bio Corp
Dr. Richman conducted research on influenza virus, herpesviruses and hemorrhagic fever viruses before focusing on HIV in the 1980s. HIV drug resistance was originally recognized in his laboratory. His lab also identified the latent HIV reservoir as the obstacle to cure with antiretroviral...
Dr Douglas Richman, Director, Center for Aids Research, University of California San Diego
Dr. Jason Rosch received his undergraduate degree from the College of Wooster with a major in biology and a minor in chemistry. He received his PhD in Molecular Microbiology and Microbial Pathogenesis from Washington University followed by a postdoctoral fellowship in Infectious Diseases at St Jude ...
Jason Rosch, Associate Member, Blue Water Vaccines
Experienced biopharma and life sciences senior manager with strong and successful background in technology development, entrepreneurship, business development, strategic planning, clinical and medical affairs, R&D, and capital formation.
Michael Salgaller, Supervisor, Invention Development And Marketing Unit, National Cancer Institute - NIH
William Schief Dr. William Schief is a Professor in the Immunology and Microbial Science Department at The Scripps Research Institute in La Jolla, CA, Director for Vaccine Design at the International AIDS Vaccine Initiative (IAVI), and an Associate Member of the Ragon Institute of MGH, MIT and...
William Schief, Professor, Department Of Immunology And Microbiology, The Scripps Research Institute
Rafick-Pierre Sékaly, PhD, is Professor and serves as Vice-Chair of Translational Medicine in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine in Atlanta, Georgia. Dr. Sékaly is a Georgia Research Alliance Eminent Scholar. He is a member of the Cancer...
Rafick-Pierre Sékaly, Professor and Vice-Chair of Translational Medicine, Emory University - School of Medicine
Dr. Kathie Seley-Radtke is a Professor in the Department of Chemistry & Biochemistry at the University of Maryland, Baltimore County. Her medicinal chemistry research focuses on targeting coronaviruses, filoviruses, flaviviruses among other infectious diseases, using her novel “fleximer”...
Dr Kathie Seley-Radtke, Professor Chemistry & Biochemistry, University of Maryland Baltimore County
Taylor joined Todd Strategy Group in 2021 after serving as a Senior Advisor to the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. He served in this role through two administrations and the COVID-19 pandemic. He also maintained his...
Taylor Sexton, Executive Director, Medical Countermeasures Coalition, Todd Strategy Group
Dr Robert Shafer, Professor of Medicine-Infectious Diseases, Stanford University School of Medicine (USA)
Imrul Shahriar, Scientist, Eradivir Therapeutics; Graduate Research Assistant & PhD Candidate, Purdue Unviersity
Sonia Sharma’s current research focuses on using unbiased, genome-scale approaches to unravel innate immunity, the body’s early immune response to microbial pathogens and neoplastic cells, which has also been implicated as a common causal factor in many inflammatory, allergic and autoimmune...
Sonia Sharma, Assistant Professor and Director of the Division of Cell Biology, La Jolla Institute
John Shon is the Chief Technology Officer of Serimmune where he leads the development of informatics software and algorithms for the company's platforms. Dr. Shon was previously Vice President of Bioinformatics and Data Sciences at Illumina and has over a decade of experience in leadership...
John Shon, CTO, Serimmune
Dr. Quillon Simpson works at Collaborative Drug Discovery (CDD), a hosted informatics platform that helps manage, analyze, and present data generated by biotech companies, CROs, academic labs, research hospitals, agrochemical and consumer goods companies. Quillon utilizes his experience in organic...
Quillon Simpson, Business Development Scientist, Collaborative Drug Discovery Inc
Dr. William Smith is the Founder, President, and Principal Investigator of VRG and NOCCR, the AMR centers in Knoxville, TN and New Orleans, LA. He is also one of the original founders of AMR. Dr. Smith is board certified in Internal Medicine, Critical Care Medicine, Nephrology and Cardiology. He...
William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC
Ramji is cofounder and CEO of teiko.bio. Teiko’s mission is to make immune profiling a reality for clinical trials, and eventually for patients. They are making that mission happen by performing deep immune characterization using single-cell mass cytometry. Their team includes 12 PhD-trained...
Ramji Srinivasan, Chief Executive Officer, Teiko Bio Inc.
Dr. Stein has been President, CEO and Director of Cidara since January 2014. Previously he was CEO of Trius Therapeutics, Inc. from 2007 until its acquisition by Cubist Pharmaceuticals, Inc. in September 2013. During his tenure, Trius developed the antibacterial drug tedizolid, which received...
Dr Jeff Stein, President and Chief Executive Officer, Cidara Therapeutics
Lesley is Regional Vice President, Early Innovation Partnering at Johnson & Johnson Innovation, California. In this role, she leads identification, incubation, due diligence, negotiation, execution and on-boarding for high-impact partnerships and collaborations in external innovation. Lesley...
Lesley Stolz, Regional Vice President, Early Innovation Partnering, Johnson & Johnson Innovation
Nathalie Strub-Wourgaft, COVID-19 Response & Pandemic Preparedness Director,, Drugs for Neglected Diseases initiative-DNDi
Terrence L. Stull, M.D., is President of BacVax. He is responsible for the administrative and scientific direction of BacVax’s development of Bacterial Vaccine Polypeptides. His education and training include his M.D. from the University of Birmingham in Alabama, residency training at Stanford, and ...
Terrence Stull, President, BacVax
Sean Sullivan, Executive Director, Head of Technology Innovation, Arcturus Therapeutics
Dr. Julie D. Suman is the Vice President of Scientific Affairs for Aptar Pharma. She manages strategic scientific planning and Aptar’s Scientific Advisory Board. Dr. Suman is also the co-founder of Next Breath, now an Aptar Pharma company. She holds a B.S. in Pharmacy from Duquesne University...
Julie Suman, Vice President, Scientific Affairs, Next Breath, an Aptar Pharma Company
Xicheng Sun, Ph.D. Vice President, Chemistry & Manufacturing at Crestone In. Prior to his current appointment, Dr Sun was an executive director of chemistry and CFTR modulator team leader at N30 Pharmaceuticals, overseeing internal and external activities from medicinal chemistry, chemical...
Dr Xicheng Sun, Vice President, Chemistry & Manufacturing, Crestone, Inc.
Shankar Sundaram currently serves as the Director for the Center for Bioengineering at the Lawrence Livermore National Laboratory. In this capacity, he leads the laboratory’s Bioengineering strategy and technology development activities that address critical challenges in health and biosecurity. He ...
Shivshankar Sundaram, Director, Center for Bioengineering, Executive Director, Predictive Design of Biologics, Lawrence Livermore National Laboratory
Dr. Suryadevara is a senior staff scientist in the laboratory of Dr. James E. Crowe, Jr. at Vanderbilt vaccine centre and is involved in developing methods pertaining to rapid identification of therapeutic antibodies against viral infections (DARPA’s Pandemic Protection Platform program). He served ...
Naveen Suryadevara, Senior Staff Scientist, Vanderbilt Vaccine Center
Harry Sutton is Post-doctoral Scholar in the Crotty lab at the La Jolla Institute for Immunology. He completed his PhD in 2021 at the John Curtin School of Medical Research in Canberra, Australia. His primary research interests have been studying how B cells respond to vaccine targets of infectious ...
Harry Sutton, Post-doctoral Fellow, Center for Infectious Disease and Vaccine Research,, La Jolla Institute for Allergy and Immunology
As Chief Business Officer, Alex Szidon is focused on strategic transactions that will help embed Resilience into the future of next-generation preventative, regenerative and curative therapies and vaccines. In this capacity, Alex and his team support and lead risk-sharing arrangements, equity...
Alex Szidon, Chief Business Officer, Resilience
Dr. Tasker is an experienced infectious disease clinician and fellow of the American College of Physicians and the Infectious Diseases Society of America. Prior to joining Codagenix, she served as CMO of Altimmune, where she led the development and clinical testing of influenza and anthrax...
Sybil Tasker, CMO, Codagenix Inc.
Dr. Tucker completed his doctoral degree in Immunology at the University of Washington. Dr. Tucker is the Chief Scientific Officer and Vice President for Research at Vaxart, Inc, a company focused on mucosal vaccine delivery. He has published several papers in immunology and served as a grant...
Leah Tufts, Regional Director of NORAM Clinical Trial Distribution at Market, brings 15 years of knowledge and experience to the field of pharmaceutical manufacturing and distribution. She has led many domestic and international startups with a focus on authoring complex procedures and securing...
Leah Tufts, Regional Director, NORAM CTD, Marken
Dr. Takeki Uehara received his DVM degree at the Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Japan, in 2002. After his graduation, he joined Shionogi & Co., Ltd. as a research scientist. In 2008 he received his PhD degree of...
Dr Takeki Uehara, Corporate Officer, Senior Vice President, Drug Development and Regulatory Science Division, Shionogi & Co., Ltd.
Dr. Vaillant is the Chief Scientific Officer at Replicor Inc. He has more than 20 years of experience in the fields of nucleic acid chemistry, virology and drug development and is the discoverer of Replicor’s nucleic acid polymer (NAP) technology. Dr. Vaillant has authored numerous primary...
Dr Andrew Vaillant, Chief Scientific Officer, Replicor Inc.
Bernd co-founded Protinhi in 2013 and became CEO at the start of Protinhi’s operational activities in 2016. In that time he grew the company from 1 to 10 people and attracted a world leading scientific advisory board to Protinhi. Bernd has more than 25 years experience in Life Sciences R&D...
Bernd van Buuren, Chief Executive Officer, Protinhi Therapeutics
Yannick Vanloubbeeck (DVM, PhD) is Head of Immunology at GSK Vaccines R&D, based in Belgium. He has joined GSK Vaccines in 2006 to lead the preclinical development of vaccine candidates against diseases of the developing world, including malaria & tuberculosis. In his current role he is...
Yannick Vanloubbeeck, Head of Immunology, GSK
Dr. Venkataraman Sriram (Sriram) is the Chief Scientific Officer at Foundery Innovations, Inc. Sriram has over 15 years of biopharmaceutical research experience developing biological and small molecule therapeutics against immunotherapy targets. Prior to starting Foundery, Sriram was at Pionyr...
Sriram Venkataraman, CSO, Foundery Innovations
Andrew Ward obtained a B.S. in Biology from Duke University in 2001. Upon graduation he moved to The Scripps Research Institute where he obtained his Ph.D. with Ronald Milligan, Ph.D. in cryoEM (2008) and conducted his postdoctoral work in structural biology and biophysics of membrane proteins with ...
Andrew Ward, Professor, Scripps Research
Ariel Weinberger, Chief Executive Officer, Autonomous
Dr Daniela Weiskopf has devoted her career to understanding the T cell response to viral pathogens relevant to human health and disease. In 2009 she received her PhD in Microbiology and Immunology from Innsbruck Medical University, Austria, where she performed research analyzing post-translational...
Daniela Weiskopf, Instructor, Division Of Vaccine Discovery, La Jolla Institute for Allergy and Immunology
Dr. Ethel D. Weld, MD, PhD is an assistant professor of medicine, pharmacology, and molecular sciences at the Johns Hopkins University School of Medicine. She earned her medical degree from the University of Chicago and her PhD in Clinical Investigation from the Johns Hopkins Bloomberg School of...
Ethel Weld, Assistant Professor of Medicine, The Johns Hopkins University School of Medicine
Nicholas Wilson Ph.D is a Vice President at Bristol Myers Squibb. Nick leads the Immunology & Stromal Biology group at Bristol Myers Squibb’s Tumor Microenvironment Thematic Research Center (TME TRC) located in Redwood City, California. Nick has over 15 years of industry experience in oncology...
Nicholas Wilson, Vice President, Immunology & Stromal Biology TME TRC, Bristol-Myers Squibb
Dr. Wood joined PDS Biotechnology as Chief Medical Officer in February 2019. She has overall responsibility for clinical development of the novel, immune activating Verrsamuneâ platform product pipeline targeting HPV-related pre-cancer and advanced cancers as well as a broad spectrum of solid...
Lauren V Wood, Chief Medical Officer, P.D.S. Biotechnology Corp
Sara E. Woodson, PhD is virologist and expert in emerging and re-emerging viral diseases. She is currently a Team Lead & Program Officer for the Centers for Research in Emerging Infectious Diseases (CREID) Network program within the Translational Research Section of the Virology Branch in the...
Sara Woodson, Program Officer, NIH/NIAID
Liz is Director, Early Innovation Partnering at Johnson & Johnson Innovation, California. In this role, she focuses on pharmaceutical innovation in support of the immunology and cardiovascular & metabolism businesses. Her charge is to identify licensing, collaboration, and investment...
Liz Wu, Director, Early Innovation Partnering, Johnson & Johnson Innovation
Richard T Wyatt, Ph.D., received his Doctorate in Immunology from Tufts University School of Graduate Biomedical Sciences in Boston, MA and did his postdoctoral training at the Harvard School of Medicine. Currently, Dr. Wyatt is a tenured Professor in the Department of Immunology and Microbiology...
Richard Wyatt, Professor, Department of Immunology and Microbiology, The Scripps Research Institute
Dr. Wyszynski’s main area of expertise is the assessment of drug and vaccine safety from observational data, with a special emphasis in the analysis of patterns of use and safety of drugs and vaccines during pregnancy. He received his medical degree from the University of Buenos Aires and Master...
Dr Diego Wyszynski, Chief Executive Officer, Pregistry
ARV Technologies is a start-up biotechnology company focused on developing innovative vaccines to address critical unmet medical needs in areas such as infectious diseases and oncology.
Renhuan Xu, Chief Executive Officer, ARV Technologies
Len Yaffe was the first MD to transition to Wall Street as an analyst many decades ago. He worked primarily at Montgomery Securities in San Francisco, and was recognized as a top analyst in pharmaceuticals, medical devices and drug distribution. He was early in recognizing the impact of intraocular ...
Len Yaffe, MD, Stoc*Doc Partners
Dr Priscilla Yang, Professor, Stanford University School of Medicine (USA)
Dr. Yang is responsible for leading clinical development strategy and overseeing clinical operations for Xencor’s portfolio of XmAb® drug candidates. Prior to joining Xencor in 2019, he served as senior vice president, head of clinical development and acting chief medical officer at Jazz...
Allen Yang, Senior Vice President and Chief Medical Officer, Xencor
Dr. Timur Yarovinsky is Vice President of Discovery at CaroGen Corporation. Prior to CaroGen, Dr. Yarovinsky worked as a Research Scientist at Yale University and the University of Iowa. He holds M.D. and Ph.D. from Russian State Medical University.
Timur Yarovinsky, VP of Discovery, Director of Immunology, CaroGen Corporation
Adam S. Yasgar received a B.Sc. in chemistry at the George Washington University in 2001. As an undergraduate, he discovered his scientific passion for analytical chemistry through his work using high-performance liquid chromatography/mass spectrometry to separate and identify illegal components in ...
Adam Yasgar, Staff Scientist, Biology, National Center for Advancing Translational Sciences (NCATS)
Dr. Liangfang Zhang is Joan and Irwin Jacobs Chancellor Professor of Nanoengineering and Bioengineering and Director of Chemical Engineering Program at the University of California San Diego. Dr. Zhang received his B.E. and M.S. degrees in Chemical Engineering from Tsinghua University, and his...
Dr Liangfang Zhang, Professor of Nanoengineering, University of California San Diego
